A novel core-shell nanofiber drug delivery system intended for the synergistic treatment of melanoma

Li Fang Zhu, Yufei Zheng, Jiannan Fan, Yuanfa Yao, Zeeshan Ahmad, Ming Wei Chang

Research output: Contribution to journalArticle

Abstract

Here, we introduce core-shell nanofibers based on chitosan (CS)-loaded poly (ε-caprolactone) (PCL) shell and 5-fluorouracil (5-FU)-loaded Poly(N-vinyl-2-pyrrolidone) (PVP) core for synergistic therapy of melanoma skin cancer. The yielded nanofibers exhibited an average diameter of 503 nm with high drug-encapsulating efficiency and good mechanical properties. Moreover, the burst release of 5-FU significantly inhibited melanoma skin cancer cells (B16F10 cells), and the sustained release of CS exhibited “remedying effects” on normal skin cells (L929 cells) after suffering adverse effects from 5-FU treatment. For the B16F10 cells, the early apoptosis cells increased from 0.8% to 62.2% after being treated with blended films loaded with 5-FU (2 wt%) for 24 h; for the L929 cells, the vital cells increased from 68.9% to 77.0%, and the early apoptosis of stage cells decreased from 12.3% to 10.9% after being treated with blended films with CS (8 wt%) for 24 h. In conclusion, the results introduced in this work can be a promising strategy for cancer treatment and possesses synergism potential to broaden an avenue for chemotherapeutic therapy with minimum adverse effects on normal cells.

LanguageEnglish
Article number105002
JournalEuropean Journal of Pharmaceutical Sciences
Volume137
Early online date11 Jul 2019
DOIs
Publication statusPublished - 1 Sep 2019

Fingerprint

Nanofibers
Drug Delivery Systems
Melanoma
Fluorouracil
Chitosan
Therapeutics
Skin Neoplasms
Apoptosis

Keywords

  • 5-Fluorouracil
  • Chitosan
  • Controlled release
  • Core-shell nanofiber
  • Skin cancer

Cite this

@article{1f5b32b36ee742418827378f8576dfbc,
title = "A novel core-shell nanofiber drug delivery system intended for the synergistic treatment of melanoma",
abstract = "Here, we introduce core-shell nanofibers based on chitosan (CS)-loaded poly (ε-caprolactone) (PCL) shell and 5-fluorouracil (5-FU)-loaded Poly(N-vinyl-2-pyrrolidone) (PVP) core for synergistic therapy of melanoma skin cancer. The yielded nanofibers exhibited an average diameter of 503 nm with high drug-encapsulating efficiency and good mechanical properties. Moreover, the burst release of 5-FU significantly inhibited melanoma skin cancer cells (B16F10 cells), and the sustained release of CS exhibited “remedying effects” on normal skin cells (L929 cells) after suffering adverse effects from 5-FU treatment. For the B16F10 cells, the early apoptosis cells increased from 0.8{\%} to 62.2{\%} after being treated with blended films loaded with 5-FU (2 wt{\%}) for 24 h; for the L929 cells, the vital cells increased from 68.9{\%} to 77.0{\%}, and the early apoptosis of stage cells decreased from 12.3{\%} to 10.9{\%} after being treated with blended films with CS (8 wt{\%}) for 24 h. In conclusion, the results introduced in this work can be a promising strategy for cancer treatment and possesses synergism potential to broaden an avenue for chemotherapeutic therapy with minimum adverse effects on normal cells.",
keywords = "5-Fluorouracil, Chitosan, Controlled release, Core-shell nanofiber, Skin cancer",
author = "Zhu, {Li Fang} and Yufei Zheng and Jiannan Fan and Yuanfa Yao and Zeeshan Ahmad and Chang, {Ming Wei}",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/j.ejps.2019.105002",
language = "English",
volume = "137",
journal = "European Journal of Pharmaceutical Sciences",
issn = "0928-0987",
publisher = "Elsevier",

}

A novel core-shell nanofiber drug delivery system intended for the synergistic treatment of melanoma. / Zhu, Li Fang; Zheng, Yufei; Fan, Jiannan; Yao, Yuanfa; Ahmad, Zeeshan; Chang, Ming Wei.

In: European Journal of Pharmaceutical Sciences, Vol. 137, 105002, 01.09.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A novel core-shell nanofiber drug delivery system intended for the synergistic treatment of melanoma

AU - Zhu, Li Fang

AU - Zheng, Yufei

AU - Fan, Jiannan

AU - Yao, Yuanfa

AU - Ahmad, Zeeshan

AU - Chang, Ming Wei

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Here, we introduce core-shell nanofibers based on chitosan (CS)-loaded poly (ε-caprolactone) (PCL) shell and 5-fluorouracil (5-FU)-loaded Poly(N-vinyl-2-pyrrolidone) (PVP) core for synergistic therapy of melanoma skin cancer. The yielded nanofibers exhibited an average diameter of 503 nm with high drug-encapsulating efficiency and good mechanical properties. Moreover, the burst release of 5-FU significantly inhibited melanoma skin cancer cells (B16F10 cells), and the sustained release of CS exhibited “remedying effects” on normal skin cells (L929 cells) after suffering adverse effects from 5-FU treatment. For the B16F10 cells, the early apoptosis cells increased from 0.8% to 62.2% after being treated with blended films loaded with 5-FU (2 wt%) for 24 h; for the L929 cells, the vital cells increased from 68.9% to 77.0%, and the early apoptosis of stage cells decreased from 12.3% to 10.9% after being treated with blended films with CS (8 wt%) for 24 h. In conclusion, the results introduced in this work can be a promising strategy for cancer treatment and possesses synergism potential to broaden an avenue for chemotherapeutic therapy with minimum adverse effects on normal cells.

AB - Here, we introduce core-shell nanofibers based on chitosan (CS)-loaded poly (ε-caprolactone) (PCL) shell and 5-fluorouracil (5-FU)-loaded Poly(N-vinyl-2-pyrrolidone) (PVP) core for synergistic therapy of melanoma skin cancer. The yielded nanofibers exhibited an average diameter of 503 nm with high drug-encapsulating efficiency and good mechanical properties. Moreover, the burst release of 5-FU significantly inhibited melanoma skin cancer cells (B16F10 cells), and the sustained release of CS exhibited “remedying effects” on normal skin cells (L929 cells) after suffering adverse effects from 5-FU treatment. For the B16F10 cells, the early apoptosis cells increased from 0.8% to 62.2% after being treated with blended films loaded with 5-FU (2 wt%) for 24 h; for the L929 cells, the vital cells increased from 68.9% to 77.0%, and the early apoptosis of stage cells decreased from 12.3% to 10.9% after being treated with blended films with CS (8 wt%) for 24 h. In conclusion, the results introduced in this work can be a promising strategy for cancer treatment and possesses synergism potential to broaden an avenue for chemotherapeutic therapy with minimum adverse effects on normal cells.

KW - 5-Fluorouracil

KW - Chitosan

KW - Controlled release

KW - Core-shell nanofiber

KW - Skin cancer

UR - http://www.scopus.com/inward/record.url?scp=85068888727&partnerID=8YFLogxK

U2 - 10.1016/j.ejps.2019.105002

DO - 10.1016/j.ejps.2019.105002

M3 - Article

VL - 137

JO - European Journal of Pharmaceutical Sciences

T2 - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

SN - 0928-0987

M1 - 105002

ER -